In alcune categorie di pazienti a rischio, l'uso di L-Carnitina, seppur raramente, potrebbe aumentare la frequenza e la severit di alcuni sintomi psichiatrici, tra i quali ad esempio il senso di agitazione e i disturbi del comportamento
In addition, dyslipidemia is a frequent complication after KT and is a risk factor for the development of cardiovascular disease and graft loss.23 Furthermore, most immunosuppressive drugs used in transplantation have a detrimental effect on the lipid profile.24 These alterations have not been adequately analyzed in the previously published series of KT recipients treated with GLP-1 RAs.611 In our series, we observed a significant reduction in total cholesterol and LDLc, and it is interesting to note that there were no differences in the number of subjects who received statins or in the dose of those drugs
doi:10.29252/iau.28.4.277 Yalin Bahat P, Ayhan I, Ureyen Ozdemir E, Inceboz , Oral E
11) Metabolic Syndrome Metabolic syndrome is 2 or more of the following conditions including insulin resistance, high blood pressure, blood fat abnormalities (dyslipidemia), and obesity